Arch Latinoam Nutr 60(1):99–104PubMed Johannessen C (1967) Pejibaye palm: physical and chemical analysis of the fruit. Econ Bot 21(4):371–378CrossRef Labarta RA, Weber JC (1998) Valorización económica de bienes tangibles de cinco especies arbóreas agroforestales en la cuenca amazónica peruana. Revista Forestal Centroamericana 23:12–21 Leakey RRB (1999) Potential for novel food products from agroforestry trees: a review. Food Chem 6:1–14CrossRef Lehman Danzinger H (1993) Caídas de frutos de Chontaduro (Bactris gasipaes H.B.K) en el Pacífico Central

de Colombia: Identificación y Control de los Insectos Responsables. Proyecto Costa Pacífico Fase II. Corporación Autónoma Regional del Valle del Cauca (C.V.C), Comunidad Económica Europea (C. E. E.), Buenaventura Lehmann J, Da Silva Jr JP, Schroth G, Gebauer G, Da Silva LF (2000a) Nitrogen CHIR-99021 cell line use in mixed tree crop plantations with a legume cover crop. Plant Soil 225:63–72CrossRef Lehmann J, Da Silva Jr JP, Trujillo L, Uguen

J (2000b) Legume cover crops and nutrient cycling in tropical fruit tree production. Acta Hortic 531:65–72 Lehmann J, Muraoka T, Zech W (2001) Root activity patterns in an Amazonian agroforest with fruit trees determined by 32P, 33P and 15N applications. Agrofor Syst 52:185–197CrossRef Leterme P, Garcia MF, Londoño AM, Rojas MG, Buldgen A, Souffrant WB (2005) Chemical composition and nutritive value of peach palm (Bactris gasipaes Kunth) in rats. J Sci Alvelestat in vitro Food Agr 85(9):1505–1512CrossRef Lieberei R, Gasparotto L, Preisinger H, Schroth G, Reisdorff C (2000) Characteristics of Sustainable

polyculture production systems on terra firme. In: Lieberei R, Bianchi H-K, Nintedanib (BIBF 1120) Boehm V, Reisdorff C (eds) Neotropical Ecosystems. Proceedings of the German-Brazilian Workshop, Hamburg, 2000. GKSS, Geesthacht, pp 653–660 Lopez G, Lozano N (2005) Estudio sobre el mercado del pijuayo. World Agroforestry Center (ICRAF), Lima Lubrano C, Robin JR (1997) Major compounds study in fruit pulp oils of six Guiana Palms species. Acta Bot Gallica 144(4):495–499 Lubrano C, Jr Robin, Khaiat A (1994) Fatty-acid, sterol and tocopherol composition of oil from the fruit mesocarp of 6 palm species in French-Guiana. Oleagineux 49(2):59–65 MADR (2009) Anuario estadístico de frutas y hortalizas 2004–2008. Ministerio de Agricultura y Desarrollo Rural, Republica de Colombia, Bogota McGrath DA, Comerford NB, Duryea ML (2000) Litter dynamics and monthly fluctuations in soil phosphorous availability in an Amazonian agroforest. Forest Ecol Manag 131:167–181CrossRef Medina MA, Mena A, Prohens J, Nuez F (2007) Survey of cultivated and wild edible plant species used in the Department of Chocó.

4±0.4, 2.2±0.4, and 2.2±0.5%, respectively, over weeks 9 and 10 (t-test,

p < 0.05). Lean body mass was increased in an additive manner by 2.1±0.5, 7.4±0.4, 4.0±0.4, and 8.5±0.8 kg in placebo, HMB-FA, ATP, and HMB-FA+ATP-supplemented participants, respectively (t-test, p < 0.05), and fat percentage only decreased in the HMB supplemented groups. Conclusions Our results suggest that HMB-FA, ATP, and the combination can enhance LBM, and strength, in an additive manner, with power increasing synergistically when HMB-FA and ATP are combined. These supplements also appear to blunt the typically overreaching response seen to high volume, low recovery training cycles."
“Background Co-ingesting creatine (5 g) with large amounts of glucose (e.g., 95 g) has been shown to enhance GSI-IX creatine and carbohydrate storage in muscle. It has been speculated that creatine BAY 80-6946 transport is mediated in part by glucose and insulin. The increases in creatine retention

are accompanied by an undesired caloric load and as a result, additional research has been undertaken to assess the effect of co-ingesting creatine with nutrients that may enhance insulin sensitivity. Co-ingestion of creatine (Cr) with an antihyperglycemic extract of Artemisia dracunculus (Russian tarragon (RT)), has been shown to influence plasma Cr levels comparable to co-ingestion of Cr and glucose [1]. However, other research has shown that short term (5 days) co-ingestion of Cr and RT (Cr+RT) did not enhance whole body creatine retention or muscle free creatine content [2]. The purpose of this on-going PRKACG investigation was to compare the long-term effects of resistance training in combination with either Cr+RT, or Cr with carbohydrate (Cr+CHO), or carbohydrate (PL) ingestion. Methods In a randomized, double-blind manner, 12 resistance trained males (n=8) and females (n=4) consumed either 90 g/day of dextrose + 0.38 g/day of fruit punch flavoring (PL, n=5), 84 g/day of dextrose + 6 g/day of Cr + 0.38 g/day of fruit punch flavoring (Cr+CHO, n=4), or 1,100 mg/day of RT + 6 g/day of Cr + 40 g/day of hydrolyzed collagen + 0.38 g/day of fruit punch flavoring (Cr+RT, n=3) for 8 weeks.

Participants performed 4 days per week (2 upper-body, 2 lower-body) of resistance training. Body composition via DEXA, 1 repetition maximum (1RM) on bench press and back squat, and anaerobic power were measured at weeks 0, 4, and 8. Delta scores for all dependent variables were analyzed using individual ANOVAs. Results Increases in lean body mass were significantly higher (p=0.038) after 4 weeks in the Cr+CHO (1.56 + 0.64 kg) and the Cr+RT (1.87 + 0.98 kg) groups compared to PL (0.02 + 1.08 kg). There were no other significant effects due to supplementation on body composition, 1RM bench press, 1RM back squat, or anaerobic power. Additionally, the Cr+RT group showed average improvements in strength to be equal to or greater than Cr+CHO. Also, by the end of the study, body fat decreased in the Cr+RT group (-2.42 + 6.

coli. As shown in Table 1, all quinolone-resistant E. coli (QREC) were resistant to at least one other antimicrobial and all but three of the QREC isolates were resistant to four or more non-quinolone antibacterials. Most QREC demonstrated high-level resistance to nalidixic acid with 21 of 40 of the QREC isolates showing a nalidixic acid MIC that exceeded 1024 mg/L. Among 2006 isolates, low-level resistance was more common, with the MIC50 in that year being 128 mg/L.

In both 2007 and 2008, the MIC50 was >1024 mg/L. Quinolone resistant E. coli predominantly harbour mutations in gyrA, parC or both Increasing nalidixic acid MICs, accompanied by resistance to fluoroquinolones Small molecule library order is often due to the acquisition of multiple mutations in quinolone targets. We sequenced the quinolone-resistance determining

regions Sirolimus research buy (QRDRs) of gyrA and parC in the 40 QREC isolates. As shown in Table 1, 28 (70%) of the quinolone-resistant isolates had at least one non-synonymous substitution in the QRDR of gyrA and 18 of these isolates also had one or more non-synonymous mutations in parC. Twenty-seven of the 28 isolates with at least one mutation in gyrA had a serine to leucine substitution at position 83, one of the most commonly documented resistance conferring mutations [10]. Twenty of these isolates also harboured the frequently documented aspartic acid to asparagine substitution at position 87 and all of these isolates had a nalidixic acid MIC of at least 256 mg/L. Eighteen of them were resistant to ciprofloxacin as well as nalidixic acid. Eighteen QREC isolates had non-synonymous mutations in the QRDR of parC with a serine to isoleucine

substitution at position 80, present in 16 strains, being the most common substitution (Table 1). The 2007 isolate with a Thr66Ile substitution in ParC had a single GyrA substitution, PTK6 Ser83Leu. All other isolates with ParC substitutions also had Ser83Leu and Asp87Asn substitutions in GyrA. Five isolates had more than one ParC substitution. Thr66Ile and Asn105Ser substitutions in ParC, seen in two isolates in this study, have not previously been described in E. coli but Thr66Ile has been seen in Salmonella enterica serovars Heidelberg and Mbandaka [18](Table 1). Both substitutions occur in strains with other previously described non-synonymous polymorphisms in parC and gyrA. In each case, the level and spectrum of resistance seen is not significantly greater than that for isolates that lack the novel substitution.

According to a two-tailed t-test, the P-value for this comparison was less than 0.001, indicating that the difference in core proteome size between the three B. anthracis isolates, and randomly chosen sets of three Bacillus isolates, was statistically significant. In fact, none of the 25 randomly-generated sets contained a larger core proteome than the set of B. anthracis isolates.

B. anthracis therefore satisfied our first criterion, since the three B. anthracis isolates had more similar protein content than randomly-chosen sets of three Bacillus isolates. B. anthracis also satisfied the second criterion, which stated that species should be distinct from other isolates of the same genus. Selleckchem Vismodegib Table 3 shows that the B. anthracis isolates contained 168 proteins not found in any other Bacillus isolate, compared to an average of just one unique protein for the 25 randomly-generated sets (P-value < 0.001). None of the 25 randomly-generated sets contained

more unique proteins than the three B. anthracis isolates. Overall, the fact that B. anthracis satisfied both criteria supports its current taxonomic classification. As another example, consider R. leguminosarum. There were Akt inhibitor 3678 proteins in its core proteome, compared to an average of 4063 for randomly selected sets of two Rhizobium isolates. This difference was not statistically significant due to the fact that only four corresponding

random groups could be created. Two of the four random Glutathione peroxidase groups–the first containing Rhizobium etli strain ATCC 51251 and R. leguminosarum strain 3841, and the second containing R. etli strain CIAT 652 and R. leguminosarum strain 3841–had larger core proteome sizes than the two R. leguminosarum isolates. The results for unique proteomes were similar, with the same two random groups having a larger unique proteome size than the two R. leguminosarum isolates. However, this apparent lack of cohesiveness can be attributed to differences in the proteome sizes of the individual isolates: the proteome of R. leguminosarum strain WSM2304 contains just 4320 proteins, compared to 5921 for the next-smallest Rhizobium isolate. As such, it might be expected that two Rhizobium isolates having proteomes much larger than that of R. leguminosarum strain WSM2304 would also have a larger core and/or unique proteome. The apparent lack of cohesiveness of Y. pestis can also be readily explained, although the reason is different than that for R. leguminosarum. There were four random groups of seven isolates each, all of which contained a mixture of Y. pestis and Yersinia pseudotuberculosis isolates, that had larger core proteomes than the seven Y. pestis isolates. All of the isolates of both Y. pestis and Y.

1a 0.06 1.0a,b,c 0.2  Alizarin red 0.5a 0.4 0.5a 0.3 2.3a,b,c 0.6  Tetracycline 0 0 0.1a 0.06 1.4a,b,c 0.4  Sum 0.6a   0.7a   4.7a,b,c   The widths of apposition bands, calcein green, alizarin red, and tetracycline in cortical surface in subtrochanteric cross sections of rat femurs (11 mm distal from femoral head) were measured by fluorescence microscopy (×400) aSham/E/PTH vs. OVX (p < 0.05) bE/PTH vs. sham (p < 0.05) cPTH vs. E (p < 0.05) Torin 1 cost Fig. 6 Transversal sections from the proximal femur (all sections 11 mm distal from

femoral head, subtrochanteric region) of OVX rats treated with PTH and E for 5 weeks and sham group. The sections were studied by fluorescence microscopy. In the sham group, only a minimal periosteal and endosteal bone formation could be observed. In the OVX group, there was no endosteal but a clear periosteal activity (B). The E-treated animals showed very weak periosteal and endosteal appositions (C). In contrast, PTH seems to induce both endosteal and periosteal bone formation (D). Please note the changes between the groups concerning bone geometry and the

width GPCR Compound Library of bone marrow (Ma.Dm) in the upper pictures Discussion Trochanteric fracture in the novel breaking test The trochanteric fracture of the human femur is one of the most frequent fracture types of osteoporotic skeleton. The trochanteric region of the rat femur shows great similarity with the trochanteric area of the human femur. Because there are many similarities between human and rat bone at the cellular and tissue levels (trabecular bone, endocortical

envelope), the use of the rat proximal femur is as good as any other routinely used non-human skeletal site for assessing bone morphometric changes [17]. The proximal (medial) part of the femoral neck in rats and other large animals seems to not be covered by periosteal tissue. This is an important factor to consider, especially when anabolic agents are tested with pronounced periosteal stimulation [18]. In contrast, the trochanteric region contains a cortical surface covered by a sufficient periosteum. Furthermore, the trochanteric region has a high content of trabecular net. The clear advantage of using the proximal femur is the opportunity it provides to measure both cortical and trabecular bone histomorphometric parameters as well as mechanical Fossariinae properties of the bone within the same skeletal area [19]. Biomechanical tests of this part of skeleton in osteoporosis studies seem to be valuable and reliable. The most conventional methods for evaluating rat hip failure force are based on the axial compression approach [14]. However, as most osteoporotic hip fractures result from lateral falls, it seems logical and necessary to establish mechanical testing methods closer to clinical conditions. In our study, the reproducibility of the biomechanical test of the rat femurs was determined by comparing the data from the right and left femurs of the non-OVX rats.

In that trial, cats were randomized to receive bleomycin ± the implant of 30 × 106 CHO cells (secreting interleukin 2) followed by the application of square pulses. The study was completed by a small cohort of untreated cats that acted as control. The authors described only one partial response however, they claimed a prolonged survival in 12 cats receiving ECT versus 11 untreated controls. This minimal response rate could be partially

due to the previous treatments that led to the development of chemoresistance. In fact, it is known that radioresistant neoplasms have increased DNA repair which is one of the described mechanisms of resistance to bleomycin as well, at least in cell lines Erlotinib concentration [15]. After this preliminary investigation, two phase I/II studies were conducted in companion animals; in the first a cohort of dogs and cats were treated with intralesional cisplatin coupled with square electric pulses [23] while in the second they received intralesional bleomycin driven by trains of biphasic pulses [19]. The overall response rate of this

second investigation was 80% with a 40% of long lasting remissions. This study evidenced that among the treated neoplasms, canine hemangiopericytomas were particularly responsive to this approach. This work check details evidenced two problems of ECT: the need of specifically tailored electrodes for the therapy of soft tissue neoplasms and the major obstacle to a smooth permeabilization represented by the high content of connective tissue within solid tumors [24]. Currently, ECT is preferentially adopted as single modality only for tumors very susceptible to electroporation such as melanomas and perianal adenomas [34–36] or relatively small in size and easily accessible like sun-induced nasal carcinomas [29]. In selected patients with cutaneous epitheliotropic and non-epitheliotropic lymphoma this therapy can lead to successful palliation or even extended local control and, consequently, survival [37]. After the development of novel electrodes [25], several phase II studies were conducted in our

Institution to evaluate the potential of ECT as adjuvant treatment after surgical cytoreduction of bulky tumors mimicking the protocols of intraoperative radiation therapy [38]. A preclinical study involving cats with soft tissue sarcomas, of evaluated the potentials of intraoperative and postoperative ECT [26]. Cats were randomized to the following groups: surgery single modality, surgery plus intraoperative ECT and surgery plus postoperative ECT. The study underlined the significant advantage offered by adjuvant ECT in terms of local control and overall survival compared to surgery alone. Time to recurrence was 12 and 19 months for the intraoperative and postoperative cohorts respectively, while the tumors treated with surgery alone recurred within an average of 4 months.

A previous study demonstrated that only a portion of P-gp molecules [11] are associated with caveolin-1, which suggests that different cell

phenotypes may modify the localization of P-gp and caveolin-1, and different cellular events may lead to redistribution of both proteins. In summary, the present study indicates that P-gp is mainly expressed in capillary endothelial cells and end-feet of glial cells. P-gp, an important part of the blood brain barrier, plays a significant role in brain tumor resistance. In addition, the expression of P-gp in the interstitial cells was related to the distance of the cells from the capillary Pritelivir price wall. The nearer the cell was to the capillary wall, the stronger the expression of P-gp. In the brain, the expression of P-gp and caveolin-1 was found at both the end-feet of astrocytes and microvascular endothelium. The parallel expression of P-gp and caveolin-1 supports the hypothesis that these two transporter proteins may work in concert to mediate transport processes in the brain at several levels, including the microvascular endothelium, the microvascular astrocytic end-feet, and parenchymal astrocytic processes. Acknowledgements This research

was supported by the National selleck compound Natural Science Foundation of China (No. 30600579). References 1. Sun H, Dai H, Shaik N, Elmquist WF: Drug efflux transporters in the CNS. Adv Drug Deliv Rev 2003, 55:83–105.PubMedCrossRef 2. Linnet K, Ejsing TB: A review on the impact

of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsychopharmacol 2008,18(3):157–169.PubMedCrossRef 3. Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG: The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 2000, 26:449–462.PubMedCrossRef 4. Demeule M, Régina A, Jodoin J, Laplante A, Dagenais C, Berthelet F, Moghrabi A, Béliveau R: Drug transport to the brain:Key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascular Pharmacology 2002, 38:339–348.PubMedCrossRef 5. Choong E, Dobrinas M, Carrupt PA, Eap CB: The permeability Orotidine 5′-phosphate decarboxylase P-glycoprotein: a focus on enantioselectivity and brain distribution. Expert Opin Drug Metab Toxicol 2010,6(8):953–65.PubMedCrossRef 6. Chen C, Liu X, Smith BJ: Utility of mdr1-gene deficient mice in assessing the impact of P-glycoprotein on the pharmacokinetics and pharmacodynamics in drug discovery and development. Curr Drug Metab 2003, 4:272–291.PubMedCrossRef 7. Sun J, He ZG, Cheng G, Wang SJ, Hao XH, Zou MJ: Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit 2004,10(1):RA5–14.PubMed 8. Demeule M, Labelle M, Régina A, Berthelet F, Béliveau R: Isolation of endothelial cell from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun 2001, 281:827–834.

5.52 nm. The molecular order of MS in the J-aggregate is improved by the HTT process leading to the significant

sharpening of the band shape together with the further red shift of the band (from 590 nm up to 597 to 599 nm). However, owing to the random growth of the J-aggregate in the film plane, the Tamoxifen reorganized J-band is ‘apparently’ isotropic. As the role of water, two different effects have been so far considered, i.e., the lubrication and hydration. We consider that the lubrication effect by the presence of water molecules contributes dominantly to the reorganization of J-aggregate while the hydration contributes a small or even negative part in the HTT process. Endnotes aWe have already reported that the hydrothermal treatment (HTT) in the temperature range of 30°C to 90°C can reorganize the original J-band to form the new J-band phase located at around 600 nm. We set the temperature of HTT at 80°C because the average diameter of the round domains is largest after HTT at 80°C in the temperature range of 30°C to 90°C [21]. Acknowledgements We would like to thank the late Prof. Michio Sugi for helpful comments and discussion. YFM would like to thank Dr. Kaoru Yoshida and Dr. Michiyo Okui for comments and guidance in FL microscopy. We would like to also

thank Ms. Hiroko Moshino, Ms. Kyoko Inoue, Mr. Jun-ichi Hoshino, and Ms. Shoukaku Hasegawa for their contribution to the early stages of this work. This work was supported Alvelestat manufacturer in part by the University-Industry Joint Research Project for Private University: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), 2007 to 2010, Grant-in-Aid for Kanagawa Academy of Science and Technology (KAST) under grant no. 0012011, and the Iketani Science and Technology Foundation under grant no. 0191134-A. References 1. Miura YF,

Ikegami K: J-Aggregates in the Langmuir and Langmuir-Blodgett films of merocyanine dyes. In J-Aggregates. Edited by: Kobayashi Baricitinib T. Singapore: World Scientific; 2012:443–514. Volume 2.CrossRef 2. Sugi M, Iizima S: Anisotropic photoconduction in dye-sensitized Langmuir films. Thin Solid Films 1980, 68:199–204.CrossRef 3. Sugi M, Fukui T, Iizima S, Iriyama K: Effect of chromophore aggregation in the Langmuir multilayer photoconductors. Mol Cryst Liq Cryst 1980, 62:165–172.CrossRef 4. Sugi M, Saito M, Fukui T, Iizima S: Effect of dye concentration in Langmuir multilayer photoconductors. Thin Solid Films 1983, 99:17–20.CrossRef 5. Sugi M, Saito M, Fukui T, Iizima S: Modification of optical and photoelectric characteristics by vapour phase treatments in Langmuir-Blodgett films of merocyanine dyes. Thin Solid Films 1985, 129:15–23.CrossRef 6. Nakahara H, Fukuda K, Moebius D, Kuhn H: Two-dimensional arrangement of chromophores in J aggregates of long-chain merocyanines and its effect on energy transfer in monolayer systems. J Phys Chem 1986, 90:6144–6148.CrossRef 7.

2, 25 mM NaNO3, 5 mM MgCl2, 500 μg/ml chloramphenicol) and harvested by centrifugation (10 min, 2800 xg, 4°C). Total RNA was extracted using Trizol reagent (Ambion) essentially as described by the manufacturer, with some modifications. Pneumococcal cells were lysed by incubation in 650 μl lysis buffer (sodium citrate 150 mM, saccharose

25 %, sodium deoxicolate 0.1 %, SDS 0.01 %) for 15 min at 37°C, followed by addition of 0.1 % SDS. After lysis, samples were selleck monoclonal humanized antibody treated with 10 U Turbo DNase (Ambion) for 1 h at 37°C. After extraction, the RNA integrity was evaluated by gel electrophoresis and its concentration determined using a Nanodrop 1000 machine (Nanodrop Technologies). For Northern blot analysis, total RNA samples were separated under denaturating conditions either by a 6 % polyacrylamide/urea 8.3 M gel in TBE buffer or by agarose MOPS/formaldehyde gel (1.3 or 1.5 %). For polyacrylamide gels, transfer of RNA onto Hybond-N+ membranes (GE Healthcare)

was performed by electroblotting (2 hours, 24 V, 4°C) in TAE buffer. For agarose gels RNA was transferred to Hybond-N+ membranes by capillarity using 20×SSC as transfer buffer. In both cases, RNA was UV cross-linked to the membrane immediately after transfer. Membranes were then hybridized in PerfectHyb Buffer https://www.selleckchem.com/products/Maraviroc.html (Sigma) for 16 h at 68°C for riboprobes and 43°C in the case of oligoprobes. After hybridization, membranes were washed as described [60]. Signals were visualized by PhosphorImaging (Storm Gel and Blot Imaging System, Amersham Bioscience) and analysed using the ImageQuant software (Molecular Dynamics). Hybridization probes Riboprobe synthesis and oligoprobe labelling was performed as previously described [60]. PCR products used as template in the riboprobe synthesis were obtained using the following primer pairs: rnm007/seqT4-3 for rnr, T7tmRNA/P2tmRNA for tmRNA and smd041T7/smd040

for smpB. The DNA probe for 16S rRNA was generated using the primer 16sR labeled at 5’ end with [γ-32P]ATP using T4 Polynucleotide kinase (Fermentas). Reverse transcription-PCR (RT-PCR) RT-PCR reactions were carried out using total RNA, with the OneStep RT-PCR kit (Qiagen), according to the supplier’s instructions. The primer pairs seqT4-2/seqT4-3 and rnm010/smd041 were used to analyse rnr Fludarabine nmr and smpB expression, respectively. Amplification of secG+rnr and rnr+smpB fragments was performed with the primer pairs smd038/smd050 and smd064/smd041, respectively. The position of these primers in S. pneumoniae genome is indicated in Figure 2a. As an independent control, 16S rRNA was amplified with specific primers 16sF/16sR. Prior to RT-PCR, all RNA samples were treated with Turbo DNA free Kit (Ambion). Control experiments, run in the absence of reverse transcriptase, yielded no product. Rapid amplification of cDNA ends (RACE) experiments 5’ RACE assays were performed according to Argaman et al.[61] with modifications.

J Int Soc Sports Nutr 2008, 5:23.PubMedCrossRef 190. Mendel RW, Hofheins JE: Metabolic responses to the acute ingestion of two commercially DNA Damage inhibitor available carbonated beverages: a pilot study. J Int Soc Sports Nutr 2007, 4:7.PubMedCrossRef 191. Rudelle S, Ferruzzi MG, Cristiani I, Moulin J, Mace K, Acheson KJ, Tappy L: Effect of a thermogenic

beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) 2007, 15:349–355.CrossRef 192. Taylor LW, Wilborn CD, Harvey T, Wismann J, Willoughby DS: Acute effects of ingesting Java Fittrade mark energy extreme functional coffee on resting energy expenditure and hemodynamic responses in male and female coffee drinkers. J Int Soc Sports Nutr 2007, 4:10.PubMedCrossRef 193. Wilborn Luminespib chemical structure C, Taylor L, Poole C, Bushey B, Williams L, Foster C, Campbell B: Effects of ingesting a commercial thermogenic product on hemodynamic function and energy expenditure at rest in males and females. Appl Physiol Nutr Metab 2009, 34:1073–1078.PubMedCrossRef 194. Roberts MD, Dalbo VJ, Hassell SE, Stout JR, Kerksick CM: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion. J Int Soc Sports Nutr 2008, 5:19.PubMedCrossRef 195. Dalbo VJ, Roberts MD, Stout JR, Kerksick CM: Acute effects of ingesting a commercial thermogenic drink on changes in energy expenditure and markers of lipolysis. J Int Soc Sports Nutr 2008, 5:6.PubMedCrossRef 196. Dalbo VJ, Roberts MD, Stout JR, Kerksick CM: Effect of gender

on the metabolic impact of a commercially available thermogenic drink. J Strength Cond Res 2010, 24:1633–1642.PubMedCrossRef 197. Rashti SL, Ratamess NA, Kang J, Faigenbaum AD, Chilakos A,

Hoffman JR: Thermogenic effect of meltdown RTD energy drink in young healthy women: a double blind, cross-over design study. Lipids Health Dis 2009, 8:57.PubMedCrossRef 198. Bloomer RJ, Canale RE, Blankenship MM, Hammond KG, Fisher-Wellman KH, Schilling BK: Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study. Lipids Health Dis 2009, 8:32.PubMedCrossRef 199. Stout J, Moon J, Tobkin S, Lockwood C, Smith A, Graef J, Kendall K, Beck T, Cramer J: Pre-workout consumption of Celsius(R) Isotretinoin enhances the benefits of chronic exercise on body composition and cardiorespiratory fitness. J Int Soc Sports Nutr 2008, 5:P8.CrossRef 200. Higgins JP, Tuttle TD, Higgins CL: Energy beverages: content and safety. Mayo Clin Proc 2010, 85:1033–1041.PubMedCrossRef 201. Sepkowitz KA: Energy drinks and caffeine-related adverse effects. JAMA 2012, 1–2. [Epub ahead of print] 202. Torpy JM, Livingston EH: Energy drinks. JAMA 2012, 1–1. [Epub ahead of print] 203. Howland JRDJ: Risks of energy drinks mixed with alcohol. JAMA 2012, 1–2. [Epub ahead of print] 204. Clauson KA, Shields KM, McQueen CE, Persad N: Safety issues associated with commercially available energy drinks.